AI-enhanced breast imaging for population screening

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, district-based cluster-controlled screening trial comparing combined AI-assisted ultrasound plus AI-assisted mammography to conventional screening (initial ultrasound followed by mammography). Districts will be grouped as clusters and assigned to the intervention or control arm, and eligible women will receive screening according to their cluster assignment. The trial will measure diagnostic accuracy, workflow efficiency, and feasibility for large-scale population screening. Screenings will be conducted at participating local centers, with coordination through Fudan University Shanghai Cancer Center.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* women aged 35 to 69 years, who were attending the "Two Cancers (Breast and Cervical Cancer) Screening" project, and had no history of breast cancer, including in-situ cancer, or any other cancers in the previous five years.

Exclusion Criteria:

* have serious cardiopulmonary insufficiency, liver or kidney insufficiency, or other systemic diseases, and a life expectancy of less than five years

Where it's running

• Fudan University Shanghai Cancer Center
  Shanghai, Shaghai, China Recruiting

Study contacts

• Study coordinator: Ying Zheng
• Email: j_shen@fudan.edu.cn
• Phone: 862164175590

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How breast density affects mammogram screening and follow-up

  This project will test whether women aged 45–75 with dense breasts have more recalls and additional diagnostic tests after routine mammograms than women with less dense breasts.

  Recruiting Azienda Sanitaria Locale CN2 Alba-Bra · Verduno, Italy/CN · NCT07415499

• Bundled breast and colorectal screening plus genetic navigation

  This program will test whether offering combined navigation for both breast and colorectal cancer screening, with genetic services when needed, helps Black and Hispanic women aged 45–74 complete recommended tests better than breast-only navigation.

  Recruiting at 2 sites Georgetown University · Newark, Delaware and 1 other locations · NCT07228000

• Single radiologist with AI support versus two radiologists for screening mammograms

  This trial will see if one radiologist aided by AI can match the performance of the usual two-radiologist reading for screening mammograms in women aged 45–69.

  Recruiting University Hospital Olomouc · Olomouc · NCT07075679

• Comparing the MAMMOMAT B.brilliant and Revelation mammography systems

  We will try two FDA‑approved mammogram machines to see which shows suspicious breast calcifications more clearly in women having diagnostic mammography.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07067788

• Screening mammograms with or without AI assistance for breast cancer detection

  This trial will try using an FDA-cleared AI tool to help radiologists read screening mammograms for adults to see if it finds more cancers and reduces unnecessary callbacks.

  Recruiting at 6 sites Phase 4 Jonsson Comprehensive Cancer Center · Los Angeles, California and 5 other locations · NCT06934239

• Using blood tests to help diagnose breast cancer

  This study is testing whether blood tests that look for specific markers can help doctors tell the difference between breast cancer and non-cancerous conditions.

  Recruiting Geneplus-Beijing Co. Ltd. · Beijing, Beijing Municipality · NCT06876610

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.